NIH AIDS Researcher Receives Immunology Award

April 16, 1998

WASHINGTON, D.C. -April 10, 1998-- William E. Paul, Chief, Laboratory of Immunology and former Director of AIDS Research at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, has been awarded the 1998 Abbott Laboratories Award in Clinical and Diagnostic Immunology. This award, which honors a scientist in the field of clinical or diagnostic immunology who has made significant contributions to understanding the immune system, will be presented at the General Meeting of the ASM, May 17-21, 1998 in Atlanta, Georgia.

Dr. Paul received his A.B. from Brooklyn College and his M.D. from the State University of New York, Brooklyn. After a medical internship and residency at the Massachusetts Memorial Hospitals in Boston, Dr. Paul began his research career in the Endocrinology Branch of the National Cancer Institute. He continued as a postdoctoral fellow in immunology at New York University School of Medicine. In 1968, Dr. Paul moved to the Laboratory of Immunology at NIAID and became its chief in 1970.

He has made contributions to the field of cytokine biology, which is the study of proteins released from human cells in response to bacterial infection. He focused on the chemicals that cause T-cell reproduction, providing insights into both allergy and cancer, which is of vital importance in developing vaccines for microbial diseases.

In addition, he and his group were the first to demonstrate that blocking the action of antigens on the surface of human cells inhibited T-cell recognition. They showed that immune response genes controlled responses by determining the formation of antigen complexes that could be recognized by T-cells.

Dr. Paul has also made major contributions to the understanding of B-cell activation to produce antibodies. He pioneered the study of B-cell activation through receptor cross-linkage and made important advances in the understanding of B-cell signaling mechanisms.

He is a fellow of the National Academy of Sciences and a member of the Institute of Medicine, past president of the American Society for Clinical Investigations and of the American Association of Immunologists, and founding editor of the Annual Reveiew of Immunology. He was nominated by John L. Fahey, University of California School of Medicine, Los Angeles.

The American Society for Microbiology, headquartered in Washington, D.C., is the oldest and largest single biological membership organization, with over 40,000 members worldwide.

American Society for Microbiology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to